Who owns CYTOKINETICS INC?
- CUSIP Number: 23282wac4
Tip: Access positions for across all investors
Analyze quarterly positions in Cytokinetics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Cytokinetics stock
Who bought or sold CYTOKINETICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Wolverine Asset Management | 79M | $102M | 12% | Sep 2024 |
|
Balyasny Asset Management | 34M | $45M | -11% | Jun 2024 |
|
Lazard Asset Management | 31M | $40M | 11% | Sep 2024 |
|
Point72 Asset Management | 30M | $38M | -16% | Sep 2024 |
|
D. E. Shaw & Co | 22M | $28M | -6% | Sep 2024 |
|
Readystate Asset Management | 18M | $24M | 100% | Sep 2024 |
|
Aequim Alternative Investments | 18M | $23M | 0% | Sep 2024 |
|
Polygon Management | 15M | $20M | -25% | Jun 2024 |
|
State Street Corporation | 11M | $14M | -9% | Jun 2024 |
|
DeepCurrents Investment Group | 10M | $14M | -40% | Jun 2024 |
|
Bank of America Corporation | 9.2M | $12M | -33% | Sep 2024 |
|
Morgan Stanley | 7.1M | $9.2M | 15% | Jun 2024 |
|
Schroder Investment Management Group | 5.2M | $6.7M | 100% | Jun 2024 |
|
BlackRock | 4.7M | $6.2M | 6% | Jun 2024 |
|
BlackRock | 4.3M | $5.5M | 100% | Sep 2024 |
|
SSI Investment Management | 3.7M | $4.8M | -1% | Sep 2024 |
|
Verition Fund Management | 3.3M | $4.3M | -40% | Jun 2024 |
|
Nicholas Investments Partners | 3.0M | $3.9M | 0% | Sep 2024 |
|
Citigroup | 2.1M | $2.8M | 100% | Sep 2024 |
|
RWC Asset Management | 1.8M | $2.3M | 20% | Sep 2024 |
|
Oaktree Capital Management | 1.7M | $2.2M | 100% | Sep 2024 |
|
Royal Bank of Canada | 1.7M | $2.1M | -13% | Sep 2024 |
|
Bnp Paribas Investment Partners | 1.5M | $1.9M | 0% | Sep 2024 |
|
Amundi | 1.5M | $2.0M | 100% | Sep 2024 |
|
Invesco | 1.0M | $1.3M | -9% | Sep 2024 |
|
Nomura Holdings | 854k | $45M | 521% | Sep 2024 |
|
Agf Management | 850k | $1.1M | 100% | Sep 2024 |
|
Man Group | 800k | $1.0M | 0% | Sep 2024 |
|
Shenkman Capital Management | 400k | $521M | -20% | Sep 2024 |
|
Wells Fargo & Company | 380k | $493k | 0% | Sep 2024 |
|
Central Pacific Bank - Trust Division | 202k | $261k | 0% | Sep 2024 |
|
Bank of New York Mellon | 200k | $259k | 0% | Sep 2024 |
|
Russell Investments | 140k | $186k | 100% | Jun 2024 |
|
KBC Group NV | 100k | $130k | 0% | Sep 2024 |
|
First Hawaiian Bank | 68k | $88k | 0% | Sep 2024 |
|
Barclays | 13k | $17k | 100% | Sep 2024 |
|
Boussard & Gavaudan Investment Management | 6.0k | $7.8M | -6% | Jun 2024 |
|
Candriam Luxembourg S.C.A. | 210.00 | $275k | 100% | Jun 2024 |
|
Who sold out of Cytokinetics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Millennium Management | Jun 2024 | 31M | $41M |
CNH Partners | Jun 2024 | 20M | $26M |
Sona Asset Management | Mar 2024 | 19M | $30M |
Advent Capital Management | Jun 2024 | 8.3M | $11M |
Flow State Investments | Mar 2024 | 7.5M | $12M |
Sunrise Partners Limited Partnership | Jun 2024 | 4.3M | $5.6M |
Franklin Resources | Jun 2024 | 2.0M | $2.6M |
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | Jun 2024 | 200k | $262k |
Jane Street | Jun 2024 | 147k | $190k |
SG Americas Securities | Jun 2024 | 15k | $1.9M |